Rocket Pharmaceuticals
+$1.32 (+12.89%) Today
+$0.29 (+2.51%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RCKT and other ETFs, options, and stocks.
About RCKT
Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector (LVV) and adeno-associated viral vector (AAV) gene therapy platforms.
CEO
Gaurav D. Shah
Employees
151
Headquarters
Cranbury, New Jersey
Founded
1999
RCKT Key Statistics
Market cap
761.09M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.11M
High today
$11.60
Low today
$9.87
Open price
$10.31
Volume
873.27K
52 Week high
$49.66
52 Week low
$7.57
RCKT News
Simply Wall St17h
Insiders who purchased Rocket Pharmaceuticals, Inc. stock last year recover some losses which currently stand at US$127k - Simply Wall St
Insiders who purchased US$382k worth of Rocket Pharmaceuticals, Inc. ( ) shares over the past year recouped some of their losses after price gained 8.0% last we
Analyst ratings
100%
of 11 ratings
Buy
100%
Hold
0%
Sell
0%
RCKT Earnings
-$1.08
-$0.72
-$0.36
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 9, After Hours